A multicenter, single-arm evaluation of palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients who have experienced CINV during the previous cycle of low emetogenic chemotherapy (LEC).
A. W. Komorowski
No relevant relationships to disclose
G. R. Morrow
No relevant relationships to disclose
R. Ahmed
Employment or Leadership Position - Eisai
D. Cox
Employment or Leadership Position - Eisai
P. J. Hesketh
Consultant or Advisory Role - Eisai; Merck
Research Funding - Eisai; Merck